CClinicalTrials.gg
CompletedNCT05632796Updated Dec 1, 2022

Tailored Pfannenstiel Incision for Caesarean Delivery According to the Fetal Head Occipitofrontal Diameter

An interventional study of Adjusting the Pfannenstiel skin incision according to the occipitofrontal diameter (OFD) of the fetal head. in Incision, Surgical, Cesarean Delivery Affecting Fetus and Pfannenstiel Incision Length, sponsored by Near East University, Turkey. Completed at 1 site in Turkey. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-12-01.

Sponsored by Near East University, Turkey · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 years 5 months after the study started (first participant enrolled Jun 2017, registered Nov 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
115
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

The purpose of the study is whether the Pfannenstiel skin incision can be adjusted according to the occipitofrontal diameter (OFD) of the fetal head.

Read the detailed description

Eligable nulliparous women delivered at term by elective cesarean section in which Pfannenstiel skin incision was performed according to the occipitofrontal diameter (OFD) of the fetal head were included. Non-vertex presentaions, all emergency cesarean sections, severe preclampsia, women in active phase of the first stage of labor and second stage of labor, placenta pervia and low lying placenta, multiple pregnancies, uncontrolled gestational diabetes mellitus were excluded.

02

Conditions studied

  • Incision, Surgical
  • Cesarean Delivery Affecting Fetus
  • Pfannenstiel Incision Length
  • Fetal Occipitofrontal Diameter

Browse trials for

Keywords

  • cesarean delivery
  • Pfannenstiel incision length
  • occipitofrontal diameter
03

In context

Surgical Wound

519 studies on the registry are indexed under Surgical Wound; 71 are open to participants now.

This study's enrollment of 115 is above the median of 80 across 412 interventional studies indexed under Surgical Wound.

Browse Surgical Wound studies →

Lead sponsor

Near East University, Turkey is the lead sponsor of 44 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • The women older than 18 years
  • term nulliparous pregnancies (>37w)
  • primary elective/planned Cesarean delivery
  • fetuses with vertex presentations
  • underwent spinal anesthesia

Exclusion criteria

Exclusion Criteria:

  • all emergency cesarean sections ( fetal distress, third trimester bleeding including abruption of placenta and placenta previa bleeding, arrest of labor in the second phase)
  • cesarean delivery for severe preeclampsia
  • cesarean delivery for non-vertex fetal presentations (breech and shoulder presentation)
  • cesarean delivery for deflexion fetal head presentations (face and brow)
  • cesarean delivery during active phase of the first stage of labor
  • cesarean delivery for placenta previa or low-lying placenta,
  • cesarean delivery for multiple pregnancies
  • all cesarean deliveries with uncontrolled gestational or non-gestational diabetes mellitus
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
115 participants (actual)

Study arms

  • Experimental
    tailored pfannenstiel incision according to the fetal head OFD

    Pfannenstiel incision performed according to the occipitofrontal diameter of the fetal head

    Procedure: Adjusting the Pfannenstiel skin incision according to the occipitofrontal diameter (OFD) of the fetal head.

Interventions

  • ProcedureAdjusting the Pfannenstiel skin incision according to the occipitofrontal diameter (OFD) of the fetal head.

    All women will be subjected to regional spinal anesthesia. Pfannenstiel incision will be made according to the fetal occiputofrontal diameter, marked on the skin (Pfannenstiel incison with Kaya modification) Following blunt entry to the abdominal cavity, the uterine lower segment Kerr incision will be performed. Folllowing delivery of the baby, umblical cord will be cut and an arterial umblical cord blood sample will be taken. Placenta will be removed. 1st and 5th min. Apgar scores will be noted. Uterine incison will be sutured double-layer with 1 polyglactin 910 suture . Peritoneum and fascia, will be closed with 2-0 and 1 polyglactin 910 suture respectively. Skin incision will be sutured with continuous 3-0 rapid polyglactin 910 suture and measured with flexible ruler in centimeters following completing the skin incision closure.

06

What researchers measure

Primary outcomes

  1. Final Pfannenstiel incision length

    Pfannenstiel skin incision length measured as milimetre (mm) which was performed according to the fetal occipitofrontal diameter measured with ultrasonography before delivery

    Time frame: up to 48 months

  2. difference between the initial and the Pfannenstiel incision length

    difference between the initial incision which was adjusted according to the fetal occipitofrontal diameter and the final Pfannenstiel incision in millimetre(mm)

    Time frame: up to 48 months

  3. rate of extension of the Pfannensitel skin incision in the study population

    percentage of patients who need of extension of the Pfannensitel skin incision in which the novel technique was performed

    Time frame: up to 48 months

Secondary outcomes

  1. duration of cesarean delivery

    duration of surgery starts with from the skin incision ends with closing the skin measured with minute

    Time frame: up to 48 months

  2. time interval between uterine incision and fetal delivery

    time interval between starting the Kerr uterine incision and delivery of the fetus measured with seconds

    Time frame: up to 48 months

  3. cut of the abdominal rectus muscle during delivery of the fetus

    number of participants who need cut of the abdominal rectus muscle during delivery of the fetus

    Time frame: up to 48 months

  4. health evaluation of the newborn with Apgar scoring system

    evaluation of the of the health of the newborn with 1. min and 5. min Apgar scoring system (1-10)

    Time frame: up to 48 months

  5. evaluation of the fetal acidosis by measuring the umbilical blood ph levels

    evaluation of fetal acidosis with umbilical ph values (7.15-7.49), \< 7.1 is accepted as fetal acidosis

    Time frame: up to 48 months

07

Study locations

1 site
  • Near East University, Obstetrics and Gynecology
    Mersin, Trnc 10, Turkey
08

References and documents

Individual participant data

Plan to share: No — we may share our data upon request

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 1, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05632796
Lead sponsor
Near East University, Turkey
Responsible party
Baris KAYA (Associate Professor, Near East University, Turkey) — Principal investigator
First posted
Dec 1, 2022
Start date
Jun 1, 2017
Primary completion
Sep 30, 2021
Completion
Oct 1, 2021
Last update
Dec 1, 2022

Study contacts

baris kaya, Assos.Prof
principal investigator · Near East University Faculty of Medicine, Lefkosa-10 TRNC, Mersin, Turkey

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion